Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Advances in neuro-oncology imaging

KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

PET imaging in patients with brain metastasis—report of the RANO/PET group

N Galldiks, KJ Langen, NL Albert… - Neuro …, 2019 - academic.oup.com
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

N Galldiks, V Dunkl, G Stoffels, M Hutterer… - European journal of …, 2015 - Springer
Purpose The follow-up of glioblastoma patients after radiochemotherapy with conventional
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT

M Röhrich, A Loktev, AK Wefers, A Altmann… - European journal of …, 2019 - Springer
Purpose Targeting fibroblast activation protein (FAP) is a new diagnostic approach allowing
the visualization of tumor stroma. Here, we applied FAP-specific PET imaging to gliomas …

Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis

V Dunet, A Pomoni, A Hottinger… - Neuro …, 2015 - academic.oup.com
Background For the past decade 18F-fluoro-ethyl-l-tyrosine (FET) and 18F-fluoro-deoxy-
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy

G Ceccon, P Lohmann, G Stoffels, N Judov… - Neuro …, 2017 - academic.oup.com
Background The aim of this study was to investigate the potential of dynamic O-(2-[18F]
fluoroethyl)-L-tyrosine (18F-FET) PET for differentiating local recurrent brain metastasis from …

Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma

NL Jansen, B Suchorska, V Wenter… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Despite advances in diagnosis and the use of different therapeutic regimens in astrocytic
high-grade glioma (HGG), the prognosis for patients remains grim. Additional pretherapeutic …

From the clinician's point of view-What is the status quo of positron emission tomography in patients with brain tumors?

N Galldiks, KJ Langen, WB Pope - Neuro-oncology, 2015 - academic.oup.com
The most common type of primary brain tumor is malignant glioma. Despite intensive
therapeutic efforts, the majority of these neoplasms remain incurable. Imaging techniques …

Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy

DA Hormuth II, M Farhat, C Christenson, B Curl… - Advanced drug delivery …, 2022 - Elsevier
Immunotherapy has become a fourth pillar in the treatment of brain tumors and, when
combined with radiation therapy, may improve patient outcomes and reduce the …